FTY720 Phase II data
Posted: Thu Sep 28, 2006 2:06 am
Phase II data looks impressive. Probably 3 years from coming to market (my guess).
The following also looks interesting, but there is no data on EDSS (yet).
Ian
http://c.moreover.com/click/here.pl?j654401602&w=464753
The following also looks interesting, but there is no data on EDSS (yet).
In addition to its anti-inflammatory effects, preclinical data suggest that FTY720 may have the potential to reduce neurodegeneration and enhance repair of the central nervous system (CNS) affected by MS.
Ian
http://c.moreover.com/click/here.pl?j654401602&w=464753